title: Efficacy of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer.
abstract: Treatment and control of brain metastases are important in patients with non-small cell lung cancer (NSCLC). Whole brain radiation therapy (WBRT) has a major role in the management of brain metastasis. Recently, efficacy erlotinib plus concurrent WBRT for patients with brain metastases from NSCLC was reported. Herein, we discussed the results and commented the clinical matters in future.
authors.affiliation: Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, 390-8621, Japan. tomonobu@shinshu-u.ac.jp.
authors.forename: Tomonobu
authors.initials: T
authors.lastname: Koizumi
authors.affiliation: Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, 390-8621, Japan.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Sasaki
authors.affiliation: Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, 390-8621, Japan.
authors.forename: Akiyuki
authors.initials: A
authors.lastname: Sakamoto
authors.affiliation: Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, 390-8621, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Kobayashi
keywords: EGFR mutation; EGFR-TKI; stereotactic radiosurgery